glp-1 receptor agonists and cardiovascular outcome trials an update Cardiovascular, mortality, kidney outcomes with in patients with type 2 diabetes: a systematic review and meta-analysis of Results of cardiovascular outcomes trials

5,6 In a 12-week randomized trial, supplementation with 1,200 mg per day of berberine and 600 mg per day of cinnamon significantly reduced fasting blood glucose, HbA1c, and low-density lipoprotein (LDL) levels in patients with type 2 diabetes, without producing significant changes in body weight or BMI

However, the authors stated this is not a clinically significant difference

4,21 There is also evidence to suggest GLP-1RAs can reduce motility in the small intestine

[DOI] [PubMed] [Google Scholar] 260.Astrup A., et al

The cardiovascular side effects that sank sibutramine are still being studied

Why the Price of Weight Loss Medications is a Problem Another factor that complicates insurance coverage for weight loss medications is the high cost of these drugs